Cargando…

Cough hypersensitivity and chronic cough

Chronic cough is globally prevalent across all age groups. This disorder is challenging to treat because many pulmonary and extrapulmonary conditions can present with chronic cough, and cough can also be present without any identifiable underlying cause or be refractory to therapies that improve ass...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chung, Kian Fan, McGarvey, Lorcan, Song, Woo-Jung, Chang, Anne B., Lai, Kefang, Canning, Brendan J., Birring, Surinder S., Smith, Jaclyn A., Mazzone, Stuart B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Primer
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9244241/ https://www.ncbi.nlm.nih.gov/pubmed/35773287 http://dx.doi.org/10.1038/s41572-022-00370-w

Ejemplares similares

COUGH: consolidating a mature field for the next 5 years
por: Chung, Kian Fan, et al.
Publicado: (2011)

Anatomy and Neurophysiology of Cough: CHEST Guideline and Expert Panel Report
por: Canning, Brendan J., et al.
Publicado: (2014)

Confronting COVID-19-associated cough and the post-COVID syndrome: role of viral neurotropism, neuroinflammation, and neuroimmune responses
por: Song, Woo-Jung, et al.
Publicado: (2021)

Chronic cough: new insights and future prospects
por: Morice, Alyn, et al.
Publicado: (2021)

From bench to bedside: The role of cough hypersensitivity in chronic cough
por: Drake, Matthew G., et al.
Publicado: (2023)

Mechanisms and Rationale for Targeted Therapies in Refractory and Unexplained Chronic Cough
por: Mazzone, Stuart B., et al.
Publicado: (2020)

Treating acute cough: wet versus dry – have we got the paradigm wrong?
por: Morice, Alyn H., et al.
Publicado: (2015)

Effect of aclidinium bromide on cough and sputum symptoms in moderate-to-severe COPD in three phase III trials
por: McGarvey, Lorcan, et al.
Publicado: (2016)

Recent progress in the management of chronic cough
por: Song, Woo-Jung, et al.
Publicado: (2020)

An observational study to determine the relationship between cough frequency and markers of inflammation in severe asthma
por: Holmes, Joshua, et al.
Publicado: (2022)

Design and rationale of two phase 3 randomised controlled trials (COUGH-1 and COUGH-2) of gefapixant, a P2X3 receptor antagonist, in refractory or unexplained chronic cough
por: Muccino, David R., et al.
Publicado: (2020)

Heterogeneity of cough hypersensitivity mediated by TRPV1 and TRPA1 in patients with chronic refractory cough
por: Long, Li, et al.
Publicado: (2019)

Consensus goals and standards for specialist cough clinics: the NEUROCOUGH international Delphi study
por: Song, Woo-Jung, et al.
Publicado: (2023)

The Effect of Aclidinium on Symptoms Including Cough in Chronic Obstructive Pulmonary Disease: A Phase 4, Double-Blind, Placebo-controlled, Parallel-Group Study
por: Smith, Jaclyn A., et al.
Publicado: (2019)

Efficacy and Safety of Gefapixant for Refractory or Unexplained Chronic Cough over 52 Weeks
por: Birring, Surinder S., et al.
Publicado: (2023)

A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Phase 2b Trial of P2X3 Receptor Antagonist Sivopixant for Refractory or Unexplained Chronic Cough
por: McGarvey, Lorcan, et al.
Publicado: (2022)

Adaptive study design to assess effect of TRPV4 inhibition in patients with chronic cough
por: Ludbrook, Valerie J., et al.
Publicado: (2021)

Uncommon causes of chronic cough associated with airway eosinophilia
por: Xie, Jiaxing, et al.
Publicado: (2021)

Peripheral and central mechanisms of cough hypersensitivity
por: Singh, Nabita, et al.
Publicado: (2020)

Validation and Meaningful Change Thresholds for an Objective Cough Frequency Measurement in Chronic Cough
por: Schelfhout, Jonathan, et al.
Publicado: (2022)

Improvements in Objective and Subjective Measures of Chronic Cough with Gefapixant: A Pooled Phase 3 Efficacy Analysis of Predefined Subgroups
por: Smith, Jaclyn A., et al.
Publicado: (2022)

Characterization of Patients With Refractory or Unexplained Chronic Cough Participating in a Phase 2 Clinical Trial of the P2X3-Receptor Antagonist Gefapixant
por: Morice, Alyn H., et al.
Publicado: (2021)

Eliapixant (BAY 1817080), a P2X3 receptor antagonist, in refractory chronic cough: a randomised, placebo-controlled, crossover phase 2a study
por: Morice, Alyn, et al.
Publicado: (2021)

Cough Focused Series: progress in understanding and management of chronic cough
por: Song, Woo-Jung, et al.
Publicado: (2022)

Neurokinin-1 Receptor Inhibition and Cough
por: Turner, Richard D., et al.
Publicado: (2021)

Measuring cough: what really matters?
por: Turner, Richard Douglas, et al.
Publicado: (2023)

Objective and Subjective Measurement of Cough in Asthma: A Systematic Review of the Literature
por: Holmes, Joshua, et al.
Publicado: (2022)

Acute and chronic cough
por: McGarvey, L.P.A., et al.
Publicado: (2004)

The assessment of quality of life in acute cough with the Leicester Cough Questionnaire (LCQ-acute)
por: Yousaf, Nadia, et al.
Publicado: (2011)

Changing the paradigm for cough: does 'cough hypersensitivity' aid our understanding?
por: Song, Woo-Jung, et al.
Publicado: (2014)

The Objective Assessment of Cough Frequency in Bronchiectasis
por: Spinou, Arietta, et al.
Publicado: (2017)

Prevalence of psychomorbidity among patients with chronic cough
por: McGarvey, Lorcan PA, et al.
Publicado: (2006)

The P2X3 receptor antagonist filapixant in patients with refractory chronic cough: a randomized controlled trial
por: Friedrich, Christian, et al.
Publicado: (2023)

Adverse perception of cough in patients with severe asthma: a discrete choice experiment
por: Holmes, Joshua, et al.
Publicado: (2023)

Cough in hypereosinophilic syndrome: case report and literature review
por: Xie, Jiaxing, et al.
Publicado: (2020)

Parainfluenza 3-Induced Cough Hypersensitivity in the Guinea Pig Airways
por: Zaccone, Eric J., et al.
Publicado: (2016)

Cough in idiopathic pulmonary fibrosis
por: van Manen, Mirjam J.G., et al.
Publicado: (2016)

The present and future of cough counting tools
por: Hall, Jocelin Isabel, et al.
Publicado: (2020)

Validation of a visual analog scale for assessing cough severity in patients with chronic cough
por: Martin Nguyen, Allison, et al.
Publicado: (2021)

Assessing cough symptom severity in refractory or unexplained chronic cough: findings from patient focus groups and an international expert panel
por: Kum, Elena, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_vio1j482jms8bl3qute7q0ab82